Browse Arkansas Code titles and sections
15 U.S.C. § 2077 — Chronic Hazard Advisory Panels
Federal law — U.S. Code and appendices · legal_authorities
**(a) Appointment; purposes** The Commission shall appoint Chronic Hazard Advisory Panels (hereinafter referred to as the Panel or Panels) to advise the Commission in accordance with the provisions of [section 2080(b) of this title](https://uscode.house.gov/view.xhtml?req=granuleid:USC-prelim-title15-section2080/b&num=0&edition=prelim) respecting the chronic hazards of cancer, birth defects, and gene mutations associated with consumer products.
**(b) Composition; membership** Each Panel shall consist of 7 members appointed by the Commission from a list of nominees who shall be nominated by the President of the National Academy of Sciences from scientists—
(1) who are not officers or employees of the United States (other than employees of the National Institutes of Health, the National Toxicology Program, or the National Center for Toxicological Research), and who do not receive compensation from or have any substantial financial interest in any manufacturer, distributor, or retailer of a consumer product; and
(2) who have demonstrated the ability to critically assess chronic hazards and risks to human health presented by the exposure of humans to toxic substances or as demonstrated by the exposure of animals to such substances.
The President of the National Academy of Sciences shall nominate for each Panel a number of individuals equal to three times the number of members to be appointed to the Panel.
**(c) Chairman and Vice Chairman; election; term** The Chairman and Vice Chairman of the Panel shall be elected from among the members and shall serve for the duration of the Panel.
**(d) Majority vote** Decisions of the Panel shall be made by a majority of the Panel.
**(e) Administrative support services** The Commission shall provide each Panel with such administra
Source: Supplied U.S. Code snapshot — release unconfirmed · 15 U.S.C. § 2077
Stored review status: release_metadata_unconfirmed. A text match is a research starting point; applicability is not established.
Original supplied file — preserved unchanged
Download original Markdown file
File SHA-256: 7159dc1bb79744bdb79a4f657e52942bda1419824c694cfe44d505a3e7686011. The original may include catalog metadata, neighboring provisions, or embedded records outside this collection's scope. Search shows only the selected federal record. Historical editions and unverified snapshots are not a statement of current law.
Authority boundary: historical or unconfirmed source not current law verified.
Open the recorded source website ↗
Record provenance
Stable record: federal_law:legal_authorities:record_usc_d3fe96a17165eb602a02247d
Source file: Laws/federal/codes/united-states-code/title-15/section-2077-chronic-hazard-advisory-panels--734308f632.md
Pages: Not recorded – Not recorded
Passage SHA-256: 5279a5acbef0590edf8718096a0f2ac0e49817a73575957713be1e827d3d02dc
Source location: Title 15, Chapter 47, § 2077; chapter-047-consumer-product-safety.md
Stored source content
**(a) Appointment; purposes** The Commission shall appoint Chronic Hazard Advisory Panels (hereinafter referred to as the Panel or Panels) to advise the Commission in accordance with the provisions of [section 2080(b) of this title](https://uscode.house.gov/view.xhtml?req=granuleid:USC-prelim-title15-section2080/b&num=0&edition=prelim) respecting the chronic hazards of cancer, birth defects, and gene mutations associated with consumer products.
**(b) Composition; membership** Each Panel shall consist of 7 members appointed by the Commission from a list of nominees who shall be nominated by the President of the National Academy of Sciences from scientists—
(1) who are not officers or employees of the United States (other than employees of the National Institutes of Health, the National Toxicology Program, or the National Center for Toxicological Research), and who do not receive compensation from or have any substantial financial interest in any manufacturer, distributor, or retailer of a consumer product; and
(2) who have demonstrated the ability to critically assess chronic hazards and risks to human health presented by the exposure of humans to toxic substances or as demonstrated by the exposure of animals to such substances.
The President of the National Academy of Sciences shall nominate for each Panel a number of individuals equal to three times the number of members to be appointed to the Panel.
**(c) Chairman and Vice Chairman; election; term** The Chairman and Vice Chairman of the Panel shall be elected from among the members and shall serve for the duration of the Panel.
**(d) Majority vote** Decisions of the Panel shall be made by a majority of the Panel.
**(e) Administrative support services** The Commission shall provide each Panel with such administrative support services as it may require to carry out its duties under [section 2080 of this title](https://uscode.house.gov/view.xhtml?req=granuleid:USC-prelim-title15-section2080&num=0&edition=prelim).
**(f) Compensation** A member of a Panel appointed under subsection (a) shall be paid at a rate not to exceed the daily equivalent of the annual rate of basic pay in effect for grade GS–18 of the General Schedule for each day (including traveltime) during which the member is engaged in the actual performance of the duties of the Panel.
**(g) Requests for and disclosures of information** Each Panel shall request information and disclose information to the public, as provided in subsection (h), only through the Commission.
**(h) Information from other Federal departments and agencies**
(1) Notwithstanding any statutory restriction on the authority of agencies and departments of the Federal Government to share information, such agencies and departments shall provide the Panel with such information and data as each Panel, through the Commission, may request to carry out its duties under [section 2080 of this title](https://uscode.house.gov/view.xhtml?req=granuleid:USC-prelim-title15-section2080&num=0&edition=prelim). Each Panel may request information, through the Commission, from States, industry and other private sources as it may require to carry out its responsibilities.
(2) [Section 2055 of this title](https://uscode.house.gov/view.xhtml?req=granuleid:USC-prelim-title15-section2055&num=0&edition=prelim) shall apply to the disclosure of information by the Panel but shall not apply to the disclosure of information to the Panel.
Cross-references
Connections may be documented source relationships, shared citations or nearby passages. Each explains its basis; a connection alone does not establish applicability to your situation.
Federal law — U.S. Code and appendices · legal_authorities
**(a) Authority to regulate** The Commission shall have no authority under this chapter to regulate any risk of injury associated with a consumer product if such risk could be eliminated or reduced to a sufficient extent by actions taken under the Occupational Safety and Health Act of 1970 [[29 U.S.C. 651](https://uscode.house.gov/view.xhtml?req=granuleid:USC-prelim-title29-section651&num=0&edition=prelim) et seq.]; the Atomic Energy Act of 1954 [[42 U.S.C. 2011](https://uscode.house.gov/view.xhtml?req=granuleid:USC-prelim-title42-section2011&num=0&edition=prelim) et seq.]; or the Clean Air Act [[42 U.S.C. 7401](https://uscode.house.gov/view.xhtml?req=granuleid:USC-prelim-title42-section7401&num=0&edition=prelim) et seq.]. The Commission shall have no authority under this chapter to regulate any risk of injury associated with electronic product radiation emitted from an electronic product (as such terms are defined by sections 355(1) and (2) 11 See References in Text note below. of the Public Health Service Act) if such risk of injury may be subjected to regulation under subpart 3 1 of part F of title III of the Public Health Service Act.
**(b) Certain notices of proposed rulemaking; duties of Chronic Hazard Advisory Panel**
(1) The Commission may not issue—
(A) an advance notice of proposed rulemaking for a consumer product safety rule,
(B) a notice of proposed rulemaking for a rule under [section 2076(e) of this title](https://uscode.house.gov/view.xhtml?req=granuleid:USC-prelim-title15-section2076/e&num=0&edition=prelim), or
(C) an advance notice of proposed rulemaking for regulations under [section 1261(q)(1) of this title](https://uscode.house.gov/view.xhtml?req=granuleid:USC-prelim-title15-section1261/q/1&num=0&edition=prelim),
relating to a risk of c
Source: Supplied U.S. Code snapshot — release unconfirmed · 15 U.S.C. § 2080
Stored review status: release_metadata_unconfirmed. Explicit cross-reference supplied in source Markdown; currentness and applicability require review.
Federal law — U.S. Code and appendices · legal_authorities
**(a)** This section applies to—
(1) positions that are classified above GS–15 pursuant to section 5108; and
(2) scientific or professional positions established under section 3104;
but does not apply to—
(A) any Senior Executive Service position under section 3132; or
(B) any position in the Federal Bureau of Investigation and Drug Enforcement Administration Senior Executive Service under section 3151.
**(b)**
(1) Subject to such regulations as the Office of Personnel Management prescribes, the head of the agency concerned shall fix the rate of basic pay for any position within such agency to which this section applies. A rate fixed under this section shall be—
(A) not less than 120 percent of the minimum rate of basic pay payable for GS–15 of the General Schedule; and
(B) subject to paragraph (3), not greater than the rate of basic pay payable for level III of the Executive Schedule.
The payment of a rate of basic pay under this section shall not be subject to the pay limitation of section 5306(e) or 5373.
(2) Subject to paragraph (1), effective at the beginning of the first applicable pay period commencing on or after the first day of the month in which an adjustment takes effect under section 5303 in the rates of pay under the General Schedule, each rate of pay established under this section for positions within an agency shall be adjusted by such amount as the head of such agency considers appropriate.
(3) In the case of an agency which has a performance appraisal system which, as designed and applied, is certified under section 5307(d) as making meaningful distinctions based on relative performance, paragraph (1)(B) shall apply as if the reference to “level III” were a reference to “level II”.
(4) No employee may suffer a reduction in pay by reaso
Source: Supplied U.S. Code snapshot — release unconfirmed · 5 U.S.C. § 5376
Stored review status: release_metadata_unconfirmed. Explicit cross-reference supplied in source Markdown; currentness and applicability require review.
Federal law — U.S. Code and appendices · legal_authorities
**(a) Disclosure requirements for manufacturers or private labelers; procedures applicable**
(1) Nothing contained in this Act shall be construed to require the release of any information described by subsection (b) of [section 552 of title 5](https://uscode.house.gov/view.xhtml?req=granuleid:USC-prelim-title5-section552&num=0&edition=prelim) or which is otherwise protected by law from disclosure to the public.
(2) All information reported to or otherwise obtained by the Commission or its representative under this Act which information contains or relates to a trade secret or other matter referred to in [section 1905 of title 18](https://uscode.house.gov/view.xhtml?req=granuleid:USC-prelim-title18-section1905&num=0&edition=prelim) or subject to [section 552(b)(4) of title 5](https://uscode.house.gov/view.xhtml?req=granuleid:USC-prelim-title5-section552/b/4&num=0&edition=prelim) shall be considered confidential and shall not be disclosed.
(3) The Commission shall, prior to the disclosure of any information which will permit the public to ascertain readily the identity of a manufacturer or private labeler of a consumer product, offer such manufacturer or private labeler an opportunity to mark such information as confidential and therefore barred from disclosure under paragraph (2). A manufacturer or private labeler shall submit any such mark within 15 calendar days after the date on which it receives the Commission’s offer.
(4) All information that a manufacturer or private labeler has marked to be confidential and barred from disclosure under paragraph (2), either at the time of submission or pursuant to paragraph (3), shall not be disclosed, except in accordance with the procedures established in paragraphs (5) and (6).
(5) If the Commission determines that a docum
Source: Supplied U.S. Code snapshot — release unconfirmed · 15 U.S.C. § 2055
Stored review status: release_metadata_unconfirmed. Explicit cross-reference supplied in source Markdown; currentness and applicability require review.
Federal law — U.S. Code and appendices · legal_authorities
**(a) In general** In this chapter:
(1) **Appropriate Congressional committees** — The term “appropriate Congressional committees” means the Committee on Energy and Commerce of the House of Representatives and the Committee on Commerce, Science, and Transportation of the Senate.
(2) **Children’s product** — The term “children’s product” means a consumer product designed or intended primarily for children 12 years of age or younger. In determining whether a consumer product is primarily intended for a child 12 years of age or younger, the following factors shall be considered:
(A) A statement by a manufacturer about the intended use of such product, including a label on such product if such statement is reasonable.
(B) Whether the product is represented in its packaging, display, promotion, or advertising as appropriate for use by children 12 years of age or younger.
(C) Whether the product is commonly recognized by consumers as being intended for use by a child 12 years of age or younger.
(D) The Age Determination Guidelines issued by the Commission staff in September 2002, and any successor to such guidelines.
(3) **Commerce** — The term “commerce” means trade, traffic, commerce, or transportation—
(A) between a place in a State and any place outside thereof, or
(B) which affects trade, traffic, commerce, or transportation described in subparagraph (A).
(4) **Commission** — The term “Commission” means the Consumer Product Safety Commission, established by [section 2053 of this title](https://uscode.house.gov/view.xhtml?req=granuleid:USC-prelim-title15-section2053&num=0&edition=prelim).
(5) **Consumer product** — The term “consumer product” means any article, or component part thereof, produced or distributed (i) for sale to a consumer for use in
Source: Supplied U.S. Code snapshot — release unconfirmed · 15 U.S.C. § 2052
Stored review status: release_metadata_unconfirmed. Explicit cross-reference supplied in source Markdown; currentness and applicability require review.
Federal law — U.S. Code and appendices · legal_authorities
**(a) Prohibition on the sale of certain products containing phthalates** Beginning on the date that is 180 days after August 14, 2008, it shall be unlawful for any person to manufacture for sale, offer for sale, distribute in commerce, or import into the United States any children’s toy or child care article that contains concentrations of more than 0.1 percent of di-(2-ethylhexyl) phthalate (DEHP), dibutyl phthalate (DBP), or benzyl butyl phthalate (BBP).
**(b) Prohibition on the sale of additional products containing certain phthalates**
(1) **Interim prohibition** — Beginning on the date that is 180 days after August 14, 2008, and until a final rule is promulgated under paragraph (3), it shall be unlawful for any person to manufacture for sale, offer for sale, distribute in commerce, or import into the United States any children’s toy that can be placed in a child’s mouth or child care article that contains concentrations of more than 0.1 percent of diisononyl phthalate (DINP), diisodecyl phthalate (DIDP), or di-n-octyl phthalate (DnOP).
(2) **Chronic Hazard Advisory Panel**
(A) *Appointment* — Not earlier than 180 days after August 14, 2008, the Commission shall begin the process of appointing a Chronic Hazard Advisory Panel pursuant to the procedures of section 28 of the Consumer Product Safety Act ([15 U.S.C. 2077](https://uscode.house.gov/view.xhtml?req=granuleid:USC-prelim-title15-section2077&num=0&edition=prelim)) to study the effects on children’s health of all phthalates and phthalate alternatives as used in children’s toys and child care articles.
(B) *Examination* — The panel shall, within 18 months after its appointment under subparagraph (A), complete an examination of the full range of phthalates that are used in products for children and shall
Source: Supplied U.S. Code snapshot — release unconfirmed · 15 U.S.C. § 2057c
Stored review status: release_metadata_unconfirmed. Incoming connection: Explicit cross-reference supplied in source Markdown; currentness and applicability require review.
Federal law — U.S. Code and appendices · legal_authorities
Page 1761
TITLE 15—COMMERCE AND TRADE
§ 2078
Statutory Notes and Related Subsidiaries
DEFINITIONS
For definitions of ‘‘Commission’’ and ‘‘appropriate
Congressional committees’’ used in this section, see
section 2(a) of Pub. L. 110–314, set out as a note under
section 2051 of this title.
§ 2077. Chronic Hazard Advisory Panels
(a) Appointment; purposes
The Commission shall appoint Chronic Hazard
Advisory Panels (hereinafter referred to as the
Panel or Panels) to advise the Commission in
accordance with the provisions of section 2080(b)
of this title respecting the chronic hazards of
cancer, birth defects, and gene mutations associ-
ated with consumer products.
(b) Composition; membership
Each Panel shall consist of 7 members ap-
pointed by the Commission from a list of nomi-
nees who shall be nominated by the President of
the National Academy of Sciences from sci-
entists—
(1) who are not officers or employees of the
United States (other than employees of the
National Institutes of Health, the National
Toxicology Program, or the National Center
for Toxicological Research), and who do not
receive compensation from or have any sub-
stantial financial interest in any manufac-
turer, distributor, or retailer of a consumer
product; and
(2) who have demonstrated the ability to
critically assess chronic hazards and risks to
human health presented by the exposure of hu-
mans to toxic substances or as demonstrated
by the exposure of animals to such substances.
The President of the National Academy of
Sciences shall nominate for each Panel a num-
ber of individuals equal to three times the num-
ber of members to be appointed to the Panel.
(c) Chairman and Vice Chairman; election; term
The Chairman and Vice Chairman of the Panel
shall be elected from am
Source: Supplied 2024 U.S. Code historical extraction · 15 U.S.C. § 2077
Stored review status: historical_2024_not_currentness_verified. Same stored citation; legal effect and authority still require review.